MAP2K7 and neoplasm: Here, we show that meningeal cell-induced SERPINA3 expression at the tumor/stroma interface promotes the amplification of PI3K/AKT signaling and the reactivation of ERK in the tumor cells, thereby overcoming BRAF/MEK inhibition.